188 related articles for article (PubMed ID: 27687722)
1. Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel.
Kang RY; Yoo KS; Han HJ; Lee JY; Lee SH; Kim DW; Lee YJ
Support Care Cancer; 2017 Feb; 25(2):429-437. PubMed ID: 27687722
[TBL] [Abstract][Full Text] [Related]
2. Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy.
Parinyanitikul N; Tanpipattanakul W; Poovorawan N; Rattananupong T; Laoitthi P; Sithidetphaiboon P; Thanasanvimon S; Sriuranpong V
Support Care Cancer; 2018 Jul; 26(7):2471-2477. PubMed ID: 29435713
[TBL] [Abstract][Full Text] [Related]
3. Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy.
Yoo KE; Kang RY; Lee JY; Lee YJ; Suh SY; Kim KS; Kim HS; Lee SH; Lee BK
Support Care Cancer; 2015 Jul; 23(7):1969-77. PubMed ID: 25500718
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?
Schwartz JR
J Oncol Pharm Pract; 2012 Jun; 18(2):250-6. PubMed ID: 21807762
[TBL] [Abstract][Full Text] [Related]
5. Safe dose reduction of steroid pre-medication for docetaxel in head and neck neoplasm treatment.
Chen NX; Zhao FF; Yan F; Zhang XX
Acta Otolaryngol; 2016; 136(2):177-80. PubMed ID: 26472564
[TBL] [Abstract][Full Text] [Related]
6. Single premedication dose of dexamethasone 20 mg IV before docetaxel administration.
Chouhan JD; Herrington JD
J Oncol Pharm Pract; 2011 Sep; 17(3):155-9. PubMed ID: 20447949
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
Hsu T; Fergusson D; Stober C; Daigle K; Moledina N; Vandermeer L; Pond G; Hilton J; Hutton B; Clemons M;
Support Care Cancer; 2021 Jun; 29(6):3113-3120. PubMed ID: 33057999
[TBL] [Abstract][Full Text] [Related]
8. Cross-sensitivity between taxanes in patients with breast cancer.
Sánchez-Muñoz A; Jiménez B; García-Tapiador A; Romero-García G; Medina L; Navarro V; González-Sánchez LA; Alba E
Clin Transl Oncol; 2011 Dec; 13(12):904-6. PubMed ID: 22126735
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity.
Zhang M; Chen Z; Yang Y; Cheng H; Li C; He Q
Pak J Pharm Sci; 2017 Jan; 30(1):61-65. PubMed ID: 28603114
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.
Trudeau ME; Eisenhauer EA; Higgins BP; Letendre F; Lofters WS; Norris BD; Vandenberg TA; Delorme F; Muldal AM
J Clin Oncol; 1996 Feb; 14(2):422-8. PubMed ID: 8636752
[TBL] [Abstract][Full Text] [Related]
11. Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions.
Köppler H; Heymanns J; Weide R
Onkologie; 2001 Jun; 24(3):283-5. PubMed ID: 11455223
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.
Jacobs C; Hutton B; Mazzarello S; Smith S; Joy A; Amir E; Ibrahim MF; Gregario N; Daigle K; Eggert L; Clemons M
Support Care Cancer; 2015 Nov; 23(11):3269-75. PubMed ID: 25933700
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of bi-weekly docetaxel for recurrent or advanced gastric cancer patients whose disease progressed by prior chemotherapy.
Kimura Y; Yano H; Taniguchi H; Iwazawa T; Danno K; Kagara N; Kanoh T; Ohnishi T; Tono T; Nakano Y; Monden T; Imaoka S
Jpn J Clin Oncol; 2011 Jun; 41(6):747-51. PubMed ID: 21498408
[TBL] [Abstract][Full Text] [Related]
14. Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.
Zhou JN; Huang XE; Ye Z; Li C; Zhang Q; Lin Y; Jiang W; Sunh WL; Shi MQ; Shu YQ
Asian Pac J Cancer Prev; 2009; 10(6):1147-50. PubMed ID: 20192601
[TBL] [Abstract][Full Text] [Related]
15. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of dexamethasone premedication regimens with docetaxel chemotherapy in early HER-2 positive breast cancer: A safety net hospital experience.
Hager A; Kondle S; Agarwal A; Chintapenta M; Horadam R; Sadeghi N; Syed S
J Oncol Pharm Pract; 2024 Feb; ():10781552241232692. PubMed ID: 38425269
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of prior administration of cyclophosphamide in TC combination treatment.
Abe H; Kawai Y; Mori T; Cho H; Kubota Y; Umeda T; Tani T
Breast Cancer; 2014 Mar; 21(2):202-7. PubMed ID: 22696251
[TBL] [Abstract][Full Text] [Related]
18. Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions.
Lansinger OM; Biedermann S; He Z; Colevas AD
J Clin Oncol; 2021 Nov; 39(32):3583-3590. PubMed ID: 34357780
[TBL] [Abstract][Full Text] [Related]
19. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of oral and IV dexamethasone premedication in the prevention of docetaxel induced allergic reactions.
Masood W; Shammas S; Saleem Z; Bhutta OA; Khan I
J Oncol Pharm Pract; 2022 Jan; 28(1):96-100. PubMed ID: 33626987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
